InsiderTrades.com logo

GUD Insider Trading

Insider Ownership Percentage: 45.62%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Knight Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Knight Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Knight Therapeutics Share Price & Price History

Current Price: C$10.29
Price Change: ▲ Price Increase of +0.11 (1.08%)
As of 09/22/2026 04:00 PM ET

This chart shows the closing price history over time for GUD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Knight Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2025Sime ArmoyanInsiderSell2,500,000C$6.30C$15,750,000.00
3/19/2025Sime ArmoyanInsiderSell550,000C$6.20C$3,410,000.00
3/17/2025Sime ArmoyanInsiderSell92,200C$6.15C$567,030.00
3/13/2025Sime ArmoyanInsiderSell1,100C$6.10C$6,710.00
3/4/2025Sime ArmoyanInsiderBuy17,600C$5.48C$96,488.48
11/12/2024Sime ArmoyanInsiderBuy90,300C$5.13C$463,672.44
11/11/2024Samira SakhiaDirectorBuy20,000C$5.15C$103,000.00
9/16/2024Sime ArmoyanInsiderSell300,000C$6.13C$1,839,000.00
8/19/2024Amal KhouriSenior OfficerSell5,000C$5.78C$28,919.00
8/15/2024Amal KhouriSenior OfficerSell500C$5.75C$2,875.00
8/13/2024Amal KhouriSenior OfficerSell5,000C$5.75C$28,750.00
7/11/2024Amal KhouriSenior OfficerSell10,000C$5.70C$57,000.00
7/3/2024Amal KhouriSenior OfficerSell10,000C$5.72C$57,200.00
6/10/2024Amal KhouriSenior OfficerSell20,000C$5.80C$116,022.00
6/5/2024Jonathan Ross GoodmanDirectorBuy5,000C$5.80C$29,000.00
5/29/2024Robert Nathaniel LandeDirectorSell15,000C$5.91C$88,600.50
5/23/2024Robert Nathaniel LandeDirectorSell20,000C$5.94C$118,710.00
5/7/2024Sime ArmoyanInsiderSell15,000C$5.95C$89,250.00
4/11/2024Sime ArmoyanInsiderSell10,900C$5.95C$64,855.00
4/1/2024Sime ArmoyanInsiderBuy6,200C$5.25C$32,550.00
3/25/2024Sime ArmoyanInsiderBuy351,000C$5.25C$1,842,750.00
1/22/2024Sime ArmoyanInsiderSell28,200C$5.75C$162,150.00
1/19/2024Sime ArmoyanInsiderSell91,000C$5.75C$523,250.00
10/23/2023Sime ArmoyanInsiderBuy1,100C$4.35C$4,785.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Knight Therapeutics (TSE:GUD)

22.71% of Knight Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Knight Therapeutics logo
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.'s shares trade on the TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at www.knighttx.com or www.sedarplus.ca.
Read More on Knight Therapeutics

Today's Range

Now: C$10.29
Low: C$10.18
High: C$10.37

50 Day Range

MA: C$9.76
Low: C$9.21
High: C$10.29

52 Week Range

Now: C$10.29
Low: C$5.66
High: C$10.37

Volume

137,369 shs

Average Volume

96,442 shs

Market Capitalization

C$1.01 billion

P/E Ratio

68.60

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Knight Therapeutics?

Knight Therapeutics' top insider shareholders include:
  1. Long Zone Holdings Inc (Insider)
  2. Sime Armoyan (Insider)
  3. Jonathan Ross Goodman (Director)
  4. Robert Nathaniel Lande (Director)
  5. Samira Sakhia (Director)
  6. Arvind Utchanah (Senior Officer)
  7. Janice Jean Murray (Director)
  8. Amal Khouri (Senior Officer)
  9. Meir Jakobsohn (Director)
Learn More about top insider investors at Knight Therapeutics.